Aortic-Based Therapy for Cardiac Arrest - 11/09/11
Abstract |
After the failure of electrical countershock, the successful treatment of cardiac arrest is a function of raising aortic pressure so as to improve vital organ perfusion. Pharmacologic pressor agents have until recently been the most direct means of increasing aortic pressure. We have now begun to reevaluate direct aortic techniques including occlusion, infusion, counterpulsation, and combinations of these. Clinical studies have demonstrated that the aorta can be accessed quickly and reliably even under emergency conditions. Initial laboratory studies indicate that some nonpharmacologic aortic therapies hold promise as adjuncts to external chest compression, or even as stand-alone therapies. Considerable research will be needed to identify the most effective approach before clinical trials can be considered. [Paradis NA: Aortic-based therapy for cardiac arrest. Ann Emerg Med May 1996;27:563-568.]
Il testo completo di questo articolo è disponibile in PDF.Mappa
| From the Department of Medicine, Columbia University College of Physicians and Surgeons, and the Department of Emergency Medicine, St Luke's-Roosevelt Hospital Center, New York, New York. |
|
| Supported in part by a development grant from Reperfusion Systems, Boston. |
|
| The author holds US patent no. 5,334,142 covering the selective aortic perfusion and oxygen system. The Biopure Corporation holds US patent no. 5,084,558 (BP86-01AA) on ultrapurified polymerized bovine hemoglobin. |
|
| 47/1/71888 |
Vol 27 - N° 5
P. 563-568 - maggio 1996 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?
